Live symbol workspace

XBI market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $153.82

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$146.13

Resistance

$161.51

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$153.82

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

No prior-week baseline yet

Avg confidence across 2 calls in the last 7 days

What sources say

No news-sourced AI calls in the last 30 days.

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

XBI News Intelligence (1 articles)

AI-curated news influencing XBI price, sentiment, and trend

Explore All XBI News with AI Analysis

Economy

2 hours, 23 minutes ago

Blue Owl-Backed Latigo Files for IPO, Adding to Biotech Pipeline

Latigo Biotherapeutics Inc. filed for an initial public offering, joining a growing list of biotechnology firms considering going public as …

Impact on XBI: The news may lead to a short-term boost in biotech stocks, particularly …

Latigo Biotherapeutics Inc. has filed for an initial public offering, adding to the growing pipeline … High (70%)

View full analysis →

Bloomberg 70% confidence